Immunovant, Inc. · NASDAQ:IMVT
Venker Eric sold 14,229 Immunovant, Inc. shares (Form 4)
Traded Apr 1 to Apr 2, 2026 · Filed Apr 3, 2026
From Apr 1 to Apr 2, 2026, Venker Eric (Director, Chief Executive Officer) sold 14,229 Immunovant, Inc. shares at an average US$24.10 for US$343K, leaving 19,561 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 14,229 shares
- Price
- US$24.10 average (US$24.04 to US$24.60)
- Value
- US$343K
- Holding after
- 19,561 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Option exercise | 368,750 | US$14.46 | 368,750 | Direct |
| Apr 1, 2026 | Common Stock | Disposition | 334,960 | US$25.10 | 33,790 | Direct |
| Apr 2, 2026 | Common Stock | Sale | 12,820 | US$24.04 | 20,970 | Direct |
| Apr 2, 2026 | Common Stock | Sale | 1,409 | US$24.60 | 19,561 | Direct |
Source
Related
- Immunovant, Inc.
- Venker Eric
- Immunovant, Inc. shareholders
- Form 4 · Venker Eric · Oct 5, 2026
- Form 4 · Venker Eric · Jul 6, 2026
- Form 4 · Venker Eric · Apr 9, 2026
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026
- Form 4 · Pande Atul · Aug 28, 2026